Division of Pulmonary, Allergy and Critical Care

This research program focuses on the pathogenesis and treatment of acute lung injury.

A multidisciplinary group of basic science and clinical investigators work together to study the pathogenesis and treatment of acute lung injury. Funded by a program project and a number of RO1 grants, a focus of this group has been oxidant injury and ischemia/reperfusion injury.

Specific faculty interests include:

Steven M. Albelda, MD
  • Role of cell adhesion molecules in lung injury
  • Role of oxidants in development of ARDS

Jason Christie, MD, MSCE
  • Molecular epidemiology of acute lung injury
  • Role of oxidants in development of ARDS
  • Predictors of post-transplant lung injury
  • Outcomes after ARDS

Melpo Christofidou-Solomidou, PhD
  • Investigation of targeted antioxidant approaches to acute lung disease 
  • Investigation of the usefulness of novel utritional agents with antioxidant properties in acute and chronic lung disease

Horace Delisser, MD

  • Role of PECAM-1 in angiogenesis and tumor cell metastasis
  • Role of hyaluronan receptors (RHAMM and CD44) in angiogenesis
  • Role of cell adhesion molecules in post-natal lung development

Aron Fisher, MD
  • Role of anti-oxidant enzymes in lung injury
  • Surfactant biology

Barry Fuchs, MD
  • Improving ICU outcomes

Paul Lanken, MD
  • ARDS clinical trials
  • Bioethics in the ICU

Nilam Mangalmurti, MD
  • Mechanisms of acute lung injury in red blood cell transfusions

Nuala Meyer, MD
  • Genetic mechanisms of acute lung injury
  • Developing a cohort of sepsis patients for genetic epidemiology study

Vladimir Muzykantov, MD, PhD
  • Lung drug delivery using nanoparticles
  • Role of oxidants in endothelial cell signal transduction

Scott Worthen, MD
  • Mechanisms of lung neutrophil recruitment and activation

Share This Page: